Skip to contentZ
Zivo Bioscience, Inc.
Z
ZIVOZivo Bioscience, Inc. Q2 2013 · 10-Q
Revenue$0.00$0.00— vs Q2 2012 Net Income-$4.75M-$4.75MN/M vs Q2 2012 EPS Diluted-$0.04-$0.04N/M vs Q2 2012 Operating Income-$882,400N/M Operating Cash Flow
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Zivo Bioscience, Inc. · CIK 1101026 · Engraved from SEC EDGAR
derived
ended Jun 30, 2013 · filed Aug 13, 2013 · 44 d after period end